Results 311 to 320 of about 791,464 (334)
Some of the next articles are maybe not open access.
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial.
The Lancet, 2017 H. M. Prince, Youn H. Kim, S. Horwitz, R. Dummer, J. Scarisbrick, P. Quaglino, P. Zinzani, P. Wolter, José A. Sanches, P. Ortiz-Romero, Oleg E. Akilov, L. Geskin, J. Trotman, K. Taylor, S. Dalle, M. Weichenthal, J. Walewski, David C. Fisher, Brigitte Dréno, R. Stadler, T. Feldman, T. Kuzel, Yinghui Wang, M. C. Palanca-Wessels, E. Zagadailov, W. Trepicchio, Wenwen Zhang, Hui-Min Lin, Yi Liu, D. Huebner, M. Little, S. Whittaker, M. Duvic, D. Joske, H. M. Prince, I. Lewis, C. Jonak, F. Trautinger, O. Bechter, D. Bron, V. C. D. de Lima, José A. Sanches, R. Klasa, M. Bagot, M. Beylot‐Barry, M. D’Incan, Brigitte Dréno, F. Grange, J. Nicolay, M. Wobser, C. Assaf, C. Loquai, M. Spina, A. Bosi, P. Fattori, A. Grzanka, A. López‐Hernandez, P. Ortiz-Romero, J. R. Roca, S. Canales, T. Illidge, Rod Johnson, S. Morris, P. McKay, Oleg E. Akilov, S. Horwitz, Youn H. Kim, B. Pro, T. Kuzel, A. Lerner, H. Eradat, L. Sokol, David C. Fisher, S. Hughey +73 moresemanticscholar +1 more sourceRevisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC).
Blood, 2007 E. Olsen, E. Vonderheid, N. Pimpinelli, R. Willemze, Youn H. Kim, R. Knobler, H. Zackheim, M. Duvic, T. Estrach, S. Lamberg, G. Wood, R. Dummer, A. Ranki, G. Burg, P. Heald, M. Pittelkow, M. Bernengo, W. Sterry, L. Laroche, F. Trautinger, S. Whittaker +20 moresemanticscholar +1 more source